Share the Vaccine 'Recipe'

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

Share the Vaccine 'Recipe'

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

When the Biden administration announced support for waiving COVID vaccine patents last week, it was met with praise, relief, skepticism, and alarm among different groups—but surprise all around. Pharmaceutical giants have long fought efforts to have their intellectual property released to meet international needs. And they’ve backed it up with immense political muscle. Could this time be different? Would it disincentivize future research, as critics like Bill Gates claim? And how much (and how quickly) could it help? To understand the issue, Jim and Maeve are joined by Julie Rovner, the Chief Washington Correspondent for Kaiser Health News and host of the podcast “What The Health?” Support this show and all of The Atlantic’s journalism by becoming a subscriber at theatlantic.com/supportus. Learn more about your ad choices. Visit megaphone.fm/adchoices

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

Aucun commentaire pour le moment